Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study
نویسندگان
چکیده
منابع مشابه
Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion.
PURPOSE To evaluate the effect of intravitreal bevacizumab (Avastin) injections on visual acuity (VA) and foveal retinal thickness in patients with macular oedema secondary to branch retinal vein occlusion. METHODS A prospective, non-comparative, consecutive, interventional case series of 34 patients. Patients received repeated intravitreal injections of 1.25 mg bevacizumab. Main outcome meas...
متن کاملManagement of macular edema due to central retinal vein occlusion – The role of aflibercept
Central retinal vein occlusion (CRVO) can cause vision loss. The pathogenesis of CRVO involves a thrombus formation leading to increased retinal capillary pressure, increased vascular permeability, and possibly retinal neovascularization. Vision loss due to CRVO is commonly caused by macular edema. Multiple treatment modalities have been used to treat macular edema. Currently, the most common t...
متن کاملEffect of Bevacizumab vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due to Central Retinal Vein Occlusion: The SCORE2 Randomized Clinical Trial.
Importance Studies have established the efficacy and safety of aflibercept for the treatment of macular edema due to central retinal vein occlusion. Bevacizumab is used off-label to treat this condition despite the absence of supporting data. Objective To investigate whether bevacizumab is noninferior to aflibercept for the treatment of macular edema secondary to central retinal or hemiretina...
متن کاملthe washback effect of discretepoint vs. integrative tests on the retention of content in knowledge tests
در این پایان نامه تاثیر دو نوع تست جزیی نگر و کلی نگر بر به یادسپاری محتوا ارزیابی شده که نتایج نشان دهندهکارایی تستهای کلی نگر بیشتر از سایر آزمونها است
15 صفحه اولBevacizumab (Avastin) Therapy for Macular Oedema in Central Retinal Vein Occlusion – Long Term Results
Background: There is no proven treatment for vision loss in central retinal vein occlusion (CRVO). Bevacizumab has been reported in small series with limited followup to have a positive effect in reducing macular edema (CME) and improving vision in central retinal vein occlusion . We report long term results of Bevacizumab in central retinal vein occlusion. Methods: Prospective interventional c...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: PharmacoEconomics
سال: 2021
ISSN: 1170-7690,1179-2027
DOI: 10.1007/s40273-021-01026-5